Drugmaker Akorn recalls all its products amid Bankruptcy
Following its decision to shut down, Akorn Pharmaceuticals has issued a voluntary recall of its medications. The list of recalled products, which consists of 75 human medications and 9 veterinary drugs, is unrelated to any adverse events but is related to the company’s Chapter 7 bankruptcy filing in February, in which they decided to close. What is closing? As part of the shutdown, their quality programme will be shut down, which means “the company will not be able to support or guarantee that the products will meet all intended specifications through the labelled shelf life of the product,” according to a press release from the company. Products from Akorn were sold online to wholesalers, retailers, manufacturers, hospitals, repackagers, and consumers. Distributors are being notified of the recall by mail from the corporation, and they are being urged to do so. They further suggest that customers stop using the recalled product and notify their doctor. Customers can contact an ...